High dose rate brachytherapy for carcinoma of the cervix: Risk factors for late rectal complications

被引:22
作者
Uno, T
Itami, J
Aruga, M
Kotaka, K
Fujimoto, H
Sato, T
Minoura, S
Ito, H
机构
[1] Int Med Ctr, Dept Radiat Therapy & Oncol, Shinjuku Ku, Tokyo 162, Japan
[2] Int Med Ctr, Dept Gynecol, Shinjuku Ku, Tokyo 162, Japan
[3] Chiba Univ, Sch Med, Dept Radiol, Chiba 280, Japan
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 1998年 / 40卷 / 03期
关键词
carcinoma of uterine cervix; radiation therapy; high dose rate brachytherapy; complications; isodose volume;
D O I
10.1016/S0360-3016(97)00849-3
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To determine the incidence of late rectal complications in patients treated with high dose rate brachytherapy for FIGO Stage IIB, IIIB carcinoma of the uterine cenix, and to evaluate the treatment factors associated with an increased probability of treatment complications. Methods and Materials: Records of 100 patients with FIGO IIB and IIIB cervical carcinoma treated with definitive irradiation using high dose rate intracavitary brachytherapy (HDR-ICR) between 1977 and 1994 mere retrospectively reviewed. For each HDR-ICR session, 6-Gy isodose volume was reconstructed retrospectively and the relationship between probability of late rectal complications and several treatment factors, including a specific point dose and parameters representing isodose volume, were examined. Statistical analyses were performed to determine the treatment factors predictive of late rectal complications. Results: Of patients treated for both stages, 33% and 38% had experienced moderate to severe (Grade 2-4) complications at 3 and 5 years, respectively, Mean value of depth (L)) of 6-Gy isodose volume in HDR-ICR in patients with and without complication were 51 mm and 46 mm, respectively (p = 0.0070), A significant difference was noted in complication rate between patients with D > 51 mm and D less than or equal to 51 mm (p = 0.0023), Cumulative Point S (2 cm dorsal from the midpoint of the ovoid sources) dose (p = 0.044), and single or total point S dose by HDR-ICR (p = 0.019, each) mere significantly higher in patients who developed complication, whereas these factors did not significantly affect the probability of pelvic control. Multivariate analysis revealed that D was the independent predictor for the endpoint of actuarial complication rate (p = 0.047), No significant difference was noted in the product of L, D, and IV value (L x D x W) between patients with less than Grade 2 rectal complication and those with Grade 2-4. Conclusion: Depth of 6-Gy isodose volume determined three dimensionally (3D) has the predictive value of late rectal complications, This suggests that the shape of the high dose area in HDR-ICR influences the incidence of late rectal complications regardless of its volume. (C) 1998 Elsevier Science Inc.
引用
收藏
页码:615 / 621
页数:7
相关论文
共 50 条
[31]   WEEKLY CISPLATIN PLUS EXTERNAL-BEAM RADIOTHERAPY AND HIGH-DOSE-RATE BRACHYTHERAPY IN PATIENTS WITH LOCALLY ADVANCED-CARCINOMA OF THE CERVIX [J].
SOUHAMI, L ;
SEYMOUR, R ;
ROMAN, TN ;
STANIMIR, GW ;
TRUDEAU, M ;
CLARK, BG ;
FREEMAN, CR .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1993, 27 (04) :871-878
[32]   High-dose-rate vs. low-dose-rate intracavitary brachytherapy for carcinoma of the uterine cervix: Systematic review and meta-analysis [J].
Lee, Kang Kyoo ;
Lee, Jong Young ;
Nam, Jung Mo ;
Kim, Chun Bae ;
Park, Kyung Ran .
BRACHYTHERAPY, 2015, 14 (04) :449-457
[33]   Small cell carcinoma of the prostate after high-dose-rate brachytherapy for low-risk prostatic adenocarcinoma [J].
Komiya, Akira ;
Yasuda, Kenji ;
Nozaki, Tetsuo ;
Fujiuchi, Yasuyoshi ;
Hayashi, Shin-Ichi ;
Fuse, Hideki .
ONCOLOGY LETTERS, 2013, 5 (01) :53-56
[34]   HIGH DOSE-RATE BRACHYTHERAPY IN THE RADICAL TREATMENT OF CERVICAL CANCER. AN ANALYSIS OF DOSE EFFECTIVENESS AND INCIDENCE OF LATE RADIATION COMPLICATIONS [J].
Long, D. ;
Friedrich-Nel, H. ;
Goedhals, L. ;
Joubert, G. .
JOURNAL FOR NEW GENERATION SCIENCES, 2011, 9 (01) :81-94
[35]   Image-Guided High-Dose Rate Brachytherapy in Cervix Carcinoma Using Balloon Catheter and Belt Immobilization System [J].
Fan, Qiyong ;
Yeung, Anamaria R. ;
Amdur, Robert ;
Helmig, Richard ;
Park, Justin ;
Li, Jonathan ;
Kahler, Darren ;
Liu, Chihray ;
Lu, Bo .
TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2017, 16 (03) :257-266
[36]   HIGH-DOSE RATE AFTERLOADING INTRACAVITARY THERAPY IN CARCINOMA OF THE CERVIX [J].
ROMAN, TN ;
SOUHAMI, L ;
FREEMAN, CR ;
PLA, C ;
EVANS, MDC ;
PODGORSAK, EB ;
MENDELEW, K .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 20 (05) :921-926
[37]   Acute Toxicity and Local Response using Three Fractions of High Dose Rate (HDR) Brachytherapy for Curative Treatment of Carcinoma Cervix [J].
Ali, Nasir ;
Qureshi, Bilal Mazhar ;
Abbasi, Ahmed Nadeem ;
Hafiz, Asim ;
Khan, Benazir Mir ;
Jangda, Abdul Qadir .
JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2020, 30 (09) :974-979
[38]   Interdigitated versus sequential high-dose-rate intracavitary brachytherapy with external beam radiotherapy in locally advanced carcinoma cervix [J].
Alam, Nawed ;
Akram, Mohammad ;
Siddiqui, Shahid Ali ;
Hussain, M. A. Bilal .
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2019, 15 (06) :1254-1259
[39]   American Brachytherapy Society consensus guidelines for locally advanced carcinoma of the cervix. Part III: Low-dose-rate and pulsed-dose-rate brachytherapy [J].
Lee, Larissa J. ;
Das, Indra J. ;
Higgins, Susan A. ;
Jhingran, Anuja ;
Small, William, Jr. ;
Thomadsen, Bruce ;
Viswanathan, Akila N. ;
Wolfson, Aaron ;
Eifel, Patricia .
BRACHYTHERAPY, 2012, 11 (01) :53-57
[40]   Interfraction Dose Variations in Organs at Risk during CT-Based High-Dose-Rate Brachytherapy in Locally Advanced Carcinoma Cervix: An Early Experience of a Tertiary Care Center [J].
Sharma, Neelam ;
Semwal, Manoj K. ;
Purkayastha, Abhishek .
JOURNAL OF MEDICAL PHYSICS, 2018, 43 (02) :136-140